Latest News

AST SpaceMobile plans a mid-June triple satellite launch, keeping it on pace for its 2026 target. Despite Wall Street skepticism, strong cash and 95% integration fuel growth.

Northrop Grumman and two other large defense stocks just announced significant increases to their dividends as shares swing in 2026.

These two ambitious players are reshaping the space economy, but their distinct business profiles and paths create very different risk and reward profiles for investors.

Delek US Holdings is a high flier and one sparking debate about its value/overvalued status.

The market is buying everything AI related, but that love doesn’t extend to data centers.

These three stocks have unique and exciting growth trajectories.

Workday shares rose after the company posted solid revenue growth.

Williams-Sonoma's stock price is on track to set a fresh high as the company outperforms, produces profits, and returns capital to investors.

Few nuclear stocks actually generate revenue yet. Now, Nano Nuclear is one of them.

Coca-Cola and Nucor are two companies in the Berkshire portfolio that consistently reward shareholders with increasing dividend payouts.

Consumer sentiment just hit a new record low.

Expense ratios and dividend yields set these two tech ETFs apart, while portfolio concentration and sector exposure reveal key differences for investors.

Look beyond the headlines. XPeng recently earned its first-ever profit and is aggressively expanding its global presence.

Meta apparently bowed out from competing for a key source of the company's business.

This company is in the right industry at the right time, although it's certainly given investors plenty of bullish news to latch onto of late.

GE Vernova, Vistra, and Nextpower have plenty of room to grow.

This under-the-radar stock is up 170% over the past year, and more upside could be ahead.

The future looks bright for AI, but it's not all about AI.

AutoZone (NYSE:AZO) reported stronger fiscal third-quarter sales growth as management pointed to gains in its commercial business, new store openings and expanded parts availability, while noting that mild late-quarter weather weighed on demand in some seasonal categories. President and CEO Phil Da

Eyepoint Pharmaceuticals (NASDAQ:EYPT) executives said the company remains on track to report top-line data from its Phase 3 wet age-related macular degeneration program for DURAVYU, also known as EYP-1901, beginning in August, with a second pivotal trial expected to follow about two months later.

The federal government plans to provide hundreds of millions of dollars to a number of quantum firms to support domestic foundry and technology development.

Five high-yield names spanning pharmaceuticals, consumer staples, energy, and ETFs offer income investors compelling yields and durable businesses for a ten-year hold.

Intuitive Machines already has one $4 billion-plus NASA contract. Is it about to win another one?

Microsoft (MSFT) stock trends near $416.95 as BNP Paribas outlines a massive 33% upside target. See how 25 million paid Copilot seats and a $250B OpenAI cloud commitment fuel Microsoft's AI monopoly in 2026.